Dabur Research Foundation
Records under this name other than patents Dabur Research Foundation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Dabur Research Foundation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,322,817 | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof Formerly held Term ended Term ended Sep 23, 2019 · From the USPTO record | Term ended | Term ended Sep 23, 2019 | From the USPTO record |
| US 6,365,191 | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof Formerly held Term ended Term ended Sep 23, 2019 · From the USPTO record | Term ended | Term ended Sep 23, 2019 | From the USPTO record |
| US 6,670,345 | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid Formerly held Lapsed on the fee record Ended Dec 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2015 | From the USPTO record |
| US 6,608,174 | Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy Formerly held Lapsed on the fee record Ended Aug 19, 2015 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2015 | From the USPTO record |
| US 6,596,692 | Substance P analogs for the treatment of cancer Formerly held Lapsed on the fee record Ended Jul 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2015 | From the USPTO record |
| US 7,179,937 | Cyclopentenone derivatives for cancer therapy Formerly held Lapsed on the fee record Ended Feb 20, 2015 · From the USPTO record | Lapsed on the fee record | Ended Feb 20, 2015 | From the USPTO record |
| US 7,173,006 | Drug comprising synthetic peptide analogs for the treatment of cancer Formerly held Lapsed on the fee record Ended Feb 6, 2015 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2015 | From the USPTO record |
| US 6,489,297 | Vasoactive intestinal peptide analogs Formerly held Lapsed on the fee record Ended Dec 3, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 3, 2014 | From the USPTO record |
| US 7,781,398 | Drug comprising synthetic peptide analogs for the treatment of cancer Formerly held Lapsed on the fee record Ended Aug 24, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 24, 2014 | From the USPTO record |
| US 7,094,755 | Vasoactive intestinal peptide analogs Formerly held Lapsed on the fee record Ended Aug 22, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2014 | From the USPTO record |